| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50090-6596-0 | 50090-6596 | HUMAN PRESCRIPTION DRUG | Cabergoline | Cabergoline | TABLET | ORAL | 20230818 | N/A | ANDA | ANDA076310 | A-S Medication Solutions | CABERGOLINE | .5 mg/1 | 8 TABLET in 1 BOTTLE (50090-6596-0) |
| 23155-823-73 | 23155-823 | HUMAN PRESCRIPTION DRUG | Cabergoline | Cabergoline | TABLET | ORAL | 20220615 | N/A | ANDA | ANDA076310 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | CABERGOLINE | .5 mg/1 | 8 TABLET in 1 BOTTLE (23155-823-73) |
| 70512-860-08 | 70512-860 | HUMAN PRESCRIPTION DRUG | Cabergoline | cabergoline | TABLET | ORAL | 20230508 | N/A | ANDA | ANDA076310 | SOLA Pharmaceuticals, LLC | CABERGOLINE | .5 mg/1 | 8 TABLET in 1 BOTTLE (70512-860-08) |